Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-11-08

Clinical Trial Update: A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of Amlodipine [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing the long-term efficacy and safety of an aliskiren-based regimen against a hydrochlorothiazide-based regimen (with optional addi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine (amlodipine)
  • HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
  • Tekturna (aliskiren)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED